NIH-funded research R01 grant

NPY and anxiety link in Alzheimer’s disease modeled in rats

Official title: Prodromal Neuropeptide Y system dysfunction causes hyperexcitable amygdala circuits and anxiety in TgF344-AD rats

Funded at University of Tennessee Health Sci Ctr · NIH-11442991 · Data updated 2026-11-12

A study in an Alzheimer’s disease rat model looks at whether a brain chemical called neuropeptide Y (NPY) helps control anxiety and fear circuits that often occur with the disease.

More Anxiety research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Tennessee Health Sci Ctr
NIH-funded
Lab location1 site (Memphis, United States)
Project startSeptember 15, 2026
Project endJune 30, 2031
Funding year2026
Award (this year)$644,237
NIH project number1R01AG105095-01
Project IDNIH-11442991 on NIH RePORTER

Who could benefit from this research

Could help

Not applicable to patient participation; preclinical rat model.

Less likely to help

No direct patient participation in this preclinical study.

What this research studies

This project explores why people with Alzheimer’s often feel anxious or fearful, and whether boosting NPY in the brain can calm overactive amygdala circuits. Researchers will use TgF344-AD rats to test how NPY levels affect anxiety-like behaviors and brain activity linked to fear. The work focuses on how estrogen-related changes may influence NPY and anxiety, with the goal of identifying new directions for improving mood and behavior in people with Alzheimer’s disease. Findings could point to new avenues for therapies that reduce anxiety and potentially influence disease progression.

Why it matters

Potential benefit: If successful, the study could inform new strategies to reduce anxiety in Alzheimer’s patients and improve overall quality of life.

How similar studies have gone: Prior work suggests NPY plays a role in anxiety regulation, supporting the plausibility of this approach.

Where this research is happening

  • University of Tennessee Health Sci Ctr
    Memphis, United States
    Active

Researchers

  • Principal investigator: Dobrunz, Lynn E — University of Tennessee Health Sci Ctr
  • Study coordinator: Dobrunz, Lynn E

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.